Literature DB >> 6086216

Metabolism of cefotaxime: a review.

H B Lassman, J D Coombes.   

Abstract

Cefotaxime (CTX) sodium is a potent semisynthetic cephalosporin antibiotic that has an unusually broad spectrum of antibacterial activity. This paper discusses the metabolism of 14C-CTX in rats, dogs, and humans as well as in vitro studies in cells of rats and rabbits. Excretion of radioactivity was similar in the three species, with greater than 80% of the dose being recovered in urine. About one-third of the administered dose was eliminated unchanged. Desacetylcefotaxime. (des-CTX) was the major metabolite. Ordinarily, only the two products, both having antibacterial activity, were found in plasma. Also found in dog and human urine were two other metabolites, M2 and M3, both inactive. These metabolites were, however, found in the plasma and bile of nephrectomized rats. The metabolic pathway follows the route: CTX----des-CTX----des-CTX lactone----metabolites M2 and M3. All reactions probably occur in the liver. Differences in metabolism between the species are quantitative rather than qualitative.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6086216

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  6 in total

1.  Ascitic fluid and serum cefotaxime and desacetyl cefotaxime levels in patients treated for bacterial peritonitis.

Authors:  B A Runyon; E A Akriviadis; F R Sattler; J Cohen
Journal:  Dig Dis Sci       Date:  1991-12       Impact factor: 3.199

Review 2.  Cefotaxime. An update of its pharmacology and therapeutic use.

Authors:  P A Todd; R N Brogden
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

3.  Pharmacokinetics of cefotaxime and desacetylcefotaxime in patients with liver disease.

Authors:  R J Ko; F R Sattler; S Nichols; E Akriviadis; B Runyon; M Appleman; J L Cohen; R T Koda
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

Review 4.  Clinical pharmacokinetics of the third generation cephalosporins.

Authors:  L Balant; P Dayer; R Auckenthaler
Journal:  Clin Pharmacokinet       Date:  1985 Mar-Apr       Impact factor: 6.447

5.  Effect of a single dose of cefotaxime or ceftriaxone on human faecal flora. A double-blind study.

Authors:  M Michéa-Hamzehpour; R Auckenthaler; J Kunz; J C Pechère
Journal:  Drugs       Date:  1988       Impact factor: 9.546

6.  Population pharmacokinetics of intravenous cefotaxime indicates that higher doses are required for critically ill children.

Authors:  Stan J F Hartman; Parth J Upadhyay; Ron A A Mathôt; Michiel van der Flier; Michiel F Schreuder; Roger J Brüggemann; Catherijne A Knibbe; Saskia N de Wildt
Journal:  J Antimicrob Chemother       Date:  2022-05-29       Impact factor: 5.758

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.